Nonmelanoma Skin Cancer

Very High Risk (10 fold or greater Relative Risk)
1. Current immunosuppressive therapy after organ transplantation (especially related to SCC)
2. Personal history of skin cancer
3. Melanoma in 2 or more first degree relatives
4. Nevi numbering 100 or more, or 5 or more atypical or Dysplastic Nevi
5. PUVA therapy for Psoriasis for more than 250 treatments
Radiation exposure and other local skin damage
1. Cummulative Sun Exposure
2. Gamma radiation for Psoriasis or malignancy
3. Ultraviolet Radiation exposure (esp. before age <14)
4. Prior burn scars
5. Tanning device use
  1. Increases SCC risk by 2.5 fold and BCC risk by 1.5 fold
  2. Risk increases with younger age of first tanning device exposure
Genitourinary skin
1. Human papilloma virus (HPV) infection
2. Uncircumcised male
Miscellaneous
1. Tobacco Abuse
2. Prior Nonmelanoma Skin Cancer

Metastasis risk
1. Basal Cell Carcinoma does not metastasize
2. Squamous Cell Carcinoma metastasizes in 3-4% of cases
  1. Recurrence or metastases occur in first 2 years in >70% of cases and first 5 years in 95% of cases
Subsequent skin cancer risk (new skin cancer following previously treated skin cancer)
1. Prior Nonmelanoma Skin Cancer increases risk of subsequent skin cancer by factor of 10 over general population
  1. Three year risk: 35%
  2. Five year risk: 50%
2. Risk factors for subsequent skin cancer
  1. Male gender
  2. Age over 60 years
  3. Higher number of prior skin cancers
  4. Severe Actinic Keratosis involvement
  5. Tobacco Abuse
    1. Increases Squamous Cell Carcinoma risk by 2.0x for current smokers and 1.6x for prior smokers

See Sun Exposure (lists general preventive measures)
See Sunscreen
See Self-skin examination
Whole body skin examination
1. USPTF: Not enough evidence
2. ACS: Every 3 years for age 20 to 40 and every 1 year as of age 40 years
Niacinamide 500 mg twice daily
1. May be indicated in high risk patients with a history of Nonmelanoma Skin Cancer
2. One fewer Nonmelanoma Skin Cancer lesion developed per year while on Niacinamide
3. Chen (2014) Australas J Dermatol 55(3):169-75 +PMID:24635573 [PubMed]